The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.
Goldman Sachs MarketBeta Intl Eq ETF GSID
Morningstar’s Analysis GSID
Will GSID outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 14.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 2.39 | 20.3 Mil | Healthcare |
ASML Holding NV | 2.01 | 17.1 Mil | Technology |
Nestle SA | 1.58 | 13.4 Mil | Consumer Defensive |
AstraZeneca PLC | 1.37 | 11.6 Mil | Healthcare |
Shell PLC | 1.34 | 11.4 Mil | Energy |
Toyota Motor Corp | 1.31 | 11.1 Mil | Consumer Cyclical |
Roche Holding AG | 1.30 | 11.0 Mil | Healthcare |
SAP SE | 1.27 | 10.8 Mil | Technology |
Novartis AG Registered Shares | 1.23 | 10.4 Mil | Healthcare |
Lvmh Moet Hennessy Louis Vuitton SE | 1.08 | 9.2 Mil | Consumer Cyclical |